SCHEMBL3753530

SCHEMBL3753530

O=C(C(=O)c1ccc(/C=C/c2ccccc2)cc1)c1ccc(/C=C/c2ccccc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.67
CES2 O00748 6/20 0.64
CES1 P23141 5/20 0.64
MAPT P10636 3/20 0.54
PLIN1 O60240 2/20 0.54
LMNA P02545 2/20 0.54
RECQL P46063 2/20 0.54
PLIN5 Q00G26 2/20 0.54
ABHD5 Q8WTS1 2/20 0.54
F3 P13726 2/20 0.54
HDAC3 O15379 1/20 0.54
TNKS O95271 1/20 0.54
HDAC4 P56524 1/20 0.54
HCAR2 Q8TDS4 1/20 0.54
HDAC7 Q8WUI4 1/20 0.54
HDAC2 Q92769 1/20 0.54
HDAC10 Q969S8 1/20 0.54
HDAC11 Q96DB2 1/20 0.54
HDAC8 Q9BY41 1/20 0.54
TNKS2 Q9H2K2 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3753532 1.00 HDAC1 (0.67) HDAC1CES2CES1MAPTPLIN1
SCHEMBL27905641 0.98 CES2 (0.68) HDAC1CES2CES1MAPTPLIN1
Benzil SCHEMBL27348338 0.93 CES2 (0.70) HDAC1CES2CES1MAPTPLIN1
SCHEMBL6311364 0.91 HDAC1 (0.62) HDAC1CES2CES1MAPTPLIN1
Potassium Ion SCHEMBL6318653 0.87 HDAC1 (0.58) HDAC1CES2CES1MAPTPLIN1
SCHEMBL1927729 0.86 HDAC1 (0.67) HDAC1CES2CES1MAPTPLIN1
SCHEMBL11545296 0.86 HDAC1 (0.67) HDAC1CES2CES1MAPTPLIN1
SCHEMBL1927732 0.86 HDAC1 (0.67) HDAC1CES2CES1MAPTPLIN1
SCHEMBL8437189 0.86 HDAC1 (0.67) HDAC1CES2CES1MAPTPLIN1
SCHEMBL27792692 0.86 HDAC1 (0.67) HDAC1MAPTPLIN1LMNARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7842830-B2 Transition-metal charge-transport materials, methods of fabrication thereof, and methods of use thereof GEORGIA TECH RESEARCH CORPORATION (US) 2010-11-30 US disclosed
US-7842830-B2 Transition-metal charge-transport materials, methods of fabrication thereof, and methods of use thereof GEORGIA TECH RESEARCH CORPORATION (US) 2010-11-30 US disclosed
US-20080121870-A1 Transition-Metal Charge Transport Materials, Methods Of Fabrication Thereof, And Methods Of Use Thereof GEORGIA TECH RESEACH CORPORATION 2008-05-29 US disclosed
US-20080121870-A1 Transition-Metal Charge Transport Materials, Methods Of Fabrication Thereof, And Methods Of Use Thereof GEORGIA TECH RESEACH CORPORATION 2008-05-29 US disclosed
WO-2005123754-A2 TRANSITION-METAL CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2005-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080121870-A1 Transition-Metal Charge Transport Materials, Methods Of Fabrication Thereof, And Methods Of Use Thereof SLC39A3, SLC6A6, SLC6A9 HDAC1 3657/4885CES2 1387/4885CES1 4295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.